Sarilumab Linked to Faster Recovery in Severe COVID-19 With Hyperinflammation
This is the first study to describe the safety of IL-6 blockade with intravenous sarilumab in patients with COVID-19 pneumonia with systemic hyperinflammation.
This is the first study to describe the safety of IL-6 blockade with intravenous sarilumab in patients with COVID-19 pneumonia with systemic hyperinflammation.
The FDA has approved Orencia as a treatment for psoriatic arthritis.